Understanding the long-term effects of sarcoma on survivors
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
This study is trying to understand how surviving sarcoma affects people's health and wellbeing over time by looking at their activity levels, health data, and personal experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2100 (estimated) |
| Sex | All |
| Sponsor | Vanderbilt-Ingram Cancer Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Trial ID | NCT06482957 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the long-term impact of a sarcoma diagnosis and treatment on patients' health and wellbeing. It aims to assess various factors, including disease incidence, treatment effects, and lifestyle contributors, on both oncologic and non-oncologic outcomes. Participants will monitor their physical activity and health metrics using a FitBit device, provide biological samples, and complete surveys to gather comprehensive data. The study also seeks to identify genomic factors related to sarcoma and develop personalized monitoring tools for treatment response and disease recurrence.
Who should consider this trial
Good fit: Ideal candidates include patients of any age with a history of sarcoma, regardless of current disease status.
Not a fit: Patients without a history of sarcoma or those who are not able to participate in monitoring activities may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of long-term health issues faced by sarcoma survivors.
How similar studies have performed: Other studies have shown success in understanding survivorship issues in cancer patients, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients at any age with a history of sarcoma, with or without evidence of a persistent disease • For pediatric patients * Parent/primary caregiver of patient * Sibling of patient aged 8 years or older
Where this trial is running
Nashville, Tennessee
- Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee, United States (Recruiting)
Study contacts
- Principal investigator: Debra Friedman, MD — Vanderbilt University/Ingram Cancer Center
- Study coordinator: Vanderbilt-Ingram Services for Timely Access
- Email: cip@vumc.org
- Phone: 800-811-8480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.